Kiniksa Pharmaceuticals International, plc KNSA

75.08 (0.26) (0.35%) as of 25 Sep
Market cap
$5.9B
P/E
70.2×
Growth Flags show if company had growth for consecutive years
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio — — — — — 0.00 5.47 97.53 0.00 51.56
P/S ratio — — — — — 0.00 4.55 4.80 3.34 4.52
P/FCF ratio — — — — — 0.00 177.86 97.89 55.34 22.42
P/Operating CF — — — — — (42.74) (86.55) 300.16 75.27 56.79
P/B ratio — — — — — 4.36 2.53 2.96 3.22 5.39
EV/Sales — — — — — 0.00 3.68 4.04 2.76 3.91
EV/EBITDA — — — — — 0.00 66.63 0.00 0.00 33.60
EV/FCF — — — — — (4.26) 144.02 82.33 45.80 19.39
Current Ratio 24.47 2.70 7.37 8.68 10.46 4.38 5.16 4.34 3.30 3.79
Net Debt/EBITDA 2.34 0.70 2.85 1.39 2.09 1.18 (15.66) 9.03 5.55 (5.26)
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE 41.53% 112.39% (108.91%) (64.15%) (60.06%) (63.55%) 63.10% 3.37% (9.85%) 11.73%
ROA (46.12%) (124.80%) (55.88%) (56.16%) (53.44%) (54.24%) 52.96% 2.86% (7.80%) 8.78%
ROIC 0.00% 0.00% 0.00% 0.00% 0.00% (3,451.96%) 2.97% (6.77%) (14.63%) 31.44%
Return on Tangible Assets (44.30%) (217.70%) (37.19%) (73.51%) (52.83%) (102.25%) 92.77% 6.60% (18.63%) 15.13%
Average Days of Receivables — — — — — 37.74 20.99 28.72 35.98 8.40
Earnings Yield — — — — — (19.54%) 18.28% 1.03% (3.08%) 1.94%
Free Cash Flow Yield — — — — — (18.18%) 0.56% 1.02% 1.81% 4.46%
Free Cash Flow per Share (83.57) (27.78) (2.92) (2.99) (2.21) (2.14) 0.08 0.19 0.36 1.84
Book value per Share 206.97 16.61 9.45 4.17 5.04 2.70 5.71 6.26 6.14 7.65
Free Cash Flow (21.87) (50.29) (86.30) (161.57) (136.81) (146.71) 5.79 13.17 25.44 136.42
EV/EBIT — — — — — 0.00 83.01 0.00 0.00 34.27
Other line items

Show all line items

Columns are period end dates